APA (7th ed.) Citation

E, J., YA, T., RJ, W., EJ, M., M, K., V, T., . . . DC, L. (2022). Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles. Journal of medicinal chemistry, 65(5), 4058. https://doi.org/10.1021/acs.jmedchem.1c01564

Chicago Style (17th ed.) Citation

E, Jecs, et al. "Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles." Journal of Medicinal Chemistry 65, no. 5 (2022): 4058. https://doi.org/10.1021/acs.jmedchem.1c01564.

MLA (9th ed.) Citation

E, Jecs, et al. "Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles." Journal of Medicinal Chemistry, vol. 65, no. 5, 2022, p. 4058, https://doi.org/10.1021/acs.jmedchem.1c01564.

Warning: These citations may not always be 100% accurate.